| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Taxes paid related to net share settlement of equity award | 376,000 | - |
| Net cash provided by financing activities | 8,760,556 | 7,133,065 |
| Net increase (decrease) in cash and cash equivalents | 807,023 | 1,972,204 |
| Effect of exchange rate changes on cash | 1,965 | - |
| Cash and cash equivalents at beginning of period | 7,038,923 | - |
| Cash and cash equivalents at end of period | 7,847,911 | - |
Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. (HOTH)